华润医疗(01515.HK)联手三井及厚朴等成立医疗投资基金
华润医疗(01515.HK)公布,於上日(19日)旗下全资子公司和凯、关连公司华润健康基金管理(香港)、三井及厚朴等作为认购人分别与普通合夥人订立认购协议,当中和凯承诺注资4,000万美元到CMH Healthcare Fund。据控股股东华润健康之认购协议,华润健康则向该基金作出承诺注资合共1.6亿美元。而该基金拟筹集合共10亿美元。
公司认为,由於该基金的主要投资方向为活跃於医疗行业且具备潜力於中国扩展业务或业务范围之企业,故集团投资该基金符合集团以通过策略性收购加快发展的策略,并据此进一步提升集团於中国医疗服务业的竞争力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.